133 related articles for article (PubMed ID: 16795012)
1. Formulation and evaluation of a testosterone transdermal spray.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2006 Aug; 95(8):1693-702. PubMed ID: 16795012
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of transdermal testosterone delivery by supersaturation.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2006 Nov; 95(11):2373-9. PubMed ID: 16886189
[TBL] [Abstract][Full Text] [Related]
3. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
[TBL] [Abstract][Full Text] [Related]
4. Impact of antinucleants on transdermal delivery of testosterone from a spray.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2007 Jan; 96(1):84-92. PubMed ID: 16998787
[TBL] [Abstract][Full Text] [Related]
5. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
7. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin.
Mills PC; Magnusson BM; Cross SE
Vet J; 2006 Mar; 171(2):276-80. PubMed ID: 16490709
[TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of testosterone transdermal delivery.
Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of clotrimazole transdermal spray.
Paradkar M; Thakkar V; Soni T; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2015; 41(10):1718-25. PubMed ID: 25579237
[TBL] [Abstract][Full Text] [Related]
10. Vehicle effects on the in vitro penetration of testosterone through equine skin.
Mills PC
Vet Res Commun; 2007 Feb; 31(2):227-33. PubMed ID: 17191091
[TBL] [Abstract][Full Text] [Related]
11. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
12. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil.
Al-Saidan SM; Krishnaiah YS; Chandrasekhar DV; Lalla JK; Rama B; Jayaram B; Bhaskar P
Skin Pharmacol Physiol; 2004; 17(6):310-20. PubMed ID: 15528962
[TBL] [Abstract][Full Text] [Related]
13. Microemulsion formulations for the transdermal delivery of testosterone.
Hathout RM; Woodman TJ; Mansour S; Mortada ND; Geneidi AS; Guy RH
Eur J Pharm Sci; 2010 Jun; 40(3):188-96. PubMed ID: 20304048
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
Watkinson RM; Guy RH; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
[TBL] [Abstract][Full Text] [Related]
15. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
Choi A; Gang H; Chun I; Gwak H
Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
[TBL] [Abstract][Full Text] [Related]
16. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
17. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery.
Wiechers JW; Watkinson AC; Cross SE; Roberts MS
Int J Cosmet Sci; 2012 Dec; 34(6):525-35. PubMed ID: 22950455
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
Pannier AK; Arora V; Iversen PL; Brand RM
Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
[TBL] [Abstract][Full Text] [Related]
19. Formulation issues associated with transdermal fentanyl delivery.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
[TBL] [Abstract][Full Text] [Related]
20. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
Sintov AC; Botner S
Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
